Briefs: Zydus, Advanced Enzyme Technologies, Link Pharma Chem and ANVISA
ANVISA issues CGMP to Concord Biotech’s Unit I
ANVISA issues CGMP to Concord Biotech’s Unit I
Acquisition of exclusive commercialization rights for European markets
The Convocation ceremony was organized for students skilled and certified in Ayush
The proposed hospital will have a bed capacity of 300 beds and the investment in the project is expected to be around Rs. 500 crore
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
Launch of Indian public health standards for Ayush healthcare facilities
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
Subscribe To Our Newsletter & Stay Updated